Understanding Opioid and Fentanyl Withdrawal:
Short-acting opioids (e.g., heroin): Symptoms begin within 6-12 hours after last use, peak at 1-3 days, and subside over 5-7 days.
Long-acting opioids (e.g., methadone): Symptoms onset is delayed, appearing 24-48 hours after last dose, peaking around day 4-6, and lasting up to 10-14 days.
Fentanyl: Due to its potency and lipid solubility, withdrawal symptoms can be intense and prolonged, sometimes lasting several weeks.
Comprehensive Medical Detox: Inpatient Supervision and 24/7 Clinical Monitoring
What does inpatient detox include?
Initial medical evaluation with vital signs and withdrawal assessment
Administration of medications tailored to individual needs, including MAT options
Continuous monitoring by clinical staff to manage symptoms and prevent complications
Coordination with therapy professionals to plan subsequent treatment phases
How Medication-Assisted Treatment (MAT) Works for Opioid and Fentanyl Dependence
Key Medications and Protocols
Suboxone (buprenorphine/naloxone): A combination medication that reduces cravings and blocks opioid effects, lowering misuse potential. It is often preferred due to its ceiling effect reducing overdose risk.
Buprenorphine (mono-product): A partial opioid agonist used for induction protocols requiring careful timing to avoid precipitated withdrawal.
Methadone: A long-acting opioid agonist administered under strict supervision for reducing withdrawal and cravings.
Benefits of MAT
Stabilizes brain chemistry, reducing cravings and withdrawal severity
Supports behavioral therapies that address psychological dependence
Improves retention in treatment and reduces overdose risk
Allows flexible care plans, including maintenance, tapering, or transition to abstinence-based programs